RAF isoform selectivity of MEK inhibitors and rational design of a covalent ARAF-MEK inhibitor
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Our studies highlight the importance of the activating RAF isoform as a determinant of MEK inhibitor sensitivity and provide proof of concept for the development of MEK inhibitors that more effectively block ARAF-driven MEK signaling via covalent targeting of Cys 514 .
Appeared: Sunday, October 25. Science Advances. Peer-reviewed journal.